PATHFINDER Trial in Houston, TX

PATHFINDER

An open-label clinical trial of investigational
avapritinib for people with advanced systemic mastocytosis.

Location Description

University of Texas, MD Anderson Cancer Center has decades of experience in leadership and cancer prevention, and provides groundbreaking research and clinical care.

University of Texas Clinical Trial Location

University of Texas, MD Anderson Cancer Center
1515 Holcombe Blvd
Houston, TX 77030
Principal Investigator: Prithviraj Bose, MD